Drug major Sun Pharma on Wednesday said it has inked a licensing agreement with Sun Pharma Advanced Research Company to commercialise a medication for the treatment of neonatal seizures in the US market.
About the Author
Drug major Sun Pharma on Wednesday said it has inked a licensing agreement with Sun Pharma Advanced Research Company to commercialise a medication for the treatment of neonatal seizures in the US market.
